Announcement • Feb 25
McPherson's Limited (ASX:MCP) announces an Equity Buyback for AUD 2 million worth of its shares. McPherson's Limited (ASX:MCP) announces a share repurchase program. Under the program, the company will repurchase up to AUD 2 million worth of its shares. The purpose of program is to return capital to shareholders, optimize capital management and enhance shareholder value, while
retaining sufficient flexibility to support future growth. The program is valid till March 11, 2027. As of February 25, 2026, the company had 143,949,141 shares issued and outstanding. Announcement • Feb 16
McPherson's Limited to Report First Half, 2026 Results on Feb 25, 2026 McPherson's Limited announced that they will report first half, 2026 results on Feb 25, 2026 Announcement • Sep 29
McPherson's Limited, Annual General Meeting, Oct 31, 2025 McPherson's Limited, Annual General Meeting, Oct 31, 2025. Location: thomson geer, level 14, 60 martin place, sydney, nsw, 2000 Australia Reported Earnings • Aug 28
Full year 2025 earnings released: AU$0.12 loss per share (vs AU$0.079 loss in FY 2024) Full year 2025 results: AU$0.12 loss per share (further deteriorated from AU$0.079 loss in FY 2024). Revenue: AU$139.0m (down 3.9% from FY 2024). Net loss: AU$16.6m (loss widened 46% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Reported Earnings • Feb 27
First half 2025 earnings released: AU$0.006 loss per share (vs AU$0.011 profit in 1H 2024) First half 2025 results: AU$0.006 loss per share (down from AU$0.011 profit in 1H 2024). Revenue: AU$70.7m (down 32% from 1H 2024). Net loss: AU$1.54m (down 197% from profit in 1H 2024). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. Announcement • Feb 25
McPherson's Limited to Report First Half, 2025 Results on Feb 26, 2025 McPherson's Limited announced that they will report first half, 2025 results on Feb 26, 2025 Announcement • Oct 24
McPherson's Limited, Annual General Meeting, Nov 27, 2024 McPherson's Limited, Annual General Meeting, Nov 27, 2024. Location: the offices of thomson geer, level 14, 60 martin place, sydney, nsw, 2000., sydney Australia New Risk • Oct 16
New major risk - Revenue and earnings growth Earnings have declined by 65% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Market cap is less than US$100m (AU$57.6m market cap, or US$38.6m). Reported Earnings • Aug 30
Full year 2024 earnings released: AU$0.079 loss per share (vs AU$0.035 loss in FY 2023) Full year 2024 results: AU$0.079 loss per share (further deteriorated from AU$0.035 loss in FY 2023). Revenue: AU$144.7m (down 31% from FY 2023). Net loss: AU$11.4m (loss widened 125% from FY 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 6.2% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 28% per year, which means it is significantly lagging earnings. Announcement • Aug 21
McPherson's Limited to Report Fiscal Year 2024 Results on Aug 29, 2024 McPherson's Limited announced that they will report fiscal year 2024 results at 10:00 AM, AUS Eastern Standard Time on Aug 29, 2024 Reported Earnings • Feb 28
First half 2024 earnings released: EPS: AU$0.011 (vs AU$0.001 in 1H 2023) First half 2024 results: EPS: AU$0.011 (up from AU$0.001 in 1H 2023). Revenue: AU$103.4m (down 7.7% from 1H 2023). Net income: AU$1.58m (up AU$1.50m from 1H 2023). Profit margin: 1.5% (up from 0.1% in 1H 2023). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Global Personal Products industry. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Price Target Changed • Feb 27
Price target increased by 25% to AU$0.67 Up from AU$0.54, the current price target is provided by 1 analyst. New target price is 5.9% above last closing price of AU$0.63. Stock is up 1.2% over the past year. The company posted a net loss per share of AU$0.035 last year. Upcoming Dividend • Feb 26
Upcoming dividend of AU$0.02 per share Eligible shareholders must have bought the stock before 04 March 2024. Payment date: 22 March 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (2.0%). New Risk • Feb 13
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (AU$80.6m market cap, or US$52.6m). Announcement • Dec 18
McPherson's Limited Announces Executive Changes McPherson's Limited announced that Craig Durham has been appointed as General Counsel & Company Secretary of McPherson's commencing on 15 January 2024. Craig has previously worked in the fast-moving consumer goods industry both in Australiaand in the U.S. Prior to McPherson's, Craig has had extensive executive leadership team and legal and governance experience in both listed and unlisted environments and has worked in highly regulated industries including intelligent traffic systems, gamingtechnology and financial services. Craig holds a current practising certificate in New South Wales and is also admitted in New York, U.S. Craig replaces Linda Gough as company secretary of McPherson's. Paul Witheridge will continue as an appointed company secretary of McPherson's and is the person nominated under ASX Listing Rule 12.6 for communication with the ASX in relation to Listing Rule matters. Announcement • Oct 05
McPherson's Limited, Annual General Meeting, Nov 28, 2023 McPherson's Limited, Annual General Meeting, Nov 28, 2023, at 11:01 AUS Eastern Standard Time. Location: MA Financial Group, Level 27, 10 Carrington Street Sydney Australia Price Target Changed • Sep 01
Price target decreased by 14% to AU$0.54 Down from AU$0.62, the current price target is an average from 2 analysts. New target price is 14% above last closing price of AU$0.47. Stock is down 41% over the past year. The company is forecast to post earnings per share of AU$0.044 next year compared to a net loss per share of AU$0.035 last year. Upcoming Dividend • Aug 28
Upcoming dividend of AU$0.01 per share at 4.0% yield Eligible shareholders must have bought the stock before 04 September 2023. Payment date: 22 September 2023. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 4.0%. Lower than top quartile of Australian dividend payers (7.1%). Higher than average of industry peers (2.0%). Announcement • Aug 24
McPherson's Limited Announces Ordinary Fully Paid Dividend for the Six Months Ended June 30, 2023, Payable on September 22, 2023 McPherson's Limited announced ordinary fully paid dividend of AUD 0.01000000 for the six months ended June 30, 2023 to be paid on September 22, 2023. Ex Date is September 4, 2023. Record Date is September 5, 2023. Reported Earnings • Aug 24
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: AU$0.035 loss per share (down from AU$0.003 profit in FY 2022). Revenue: AU$210.3m (down 1.8% from FY 2022). Net loss: AU$5.06m (down AU$5.39m from profit in FY 2022). Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) were also behind analyst expectations. Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 8.3% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. Announcement • Aug 22
McPherson's Limited to Report Fiscal Year 2023 Results on Aug 24, 2023 McPherson's Limited announced that they will report fiscal year 2023 results on Aug 24, 2023 Board Change • Aug 02
Less than half of directors are independent Following MD, CEO & Director Brett Charlton's arrival on 01 August 2023, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non-Executive Director Helen Thornton was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Buying Opportunity • Jul 01
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 33%. The fair value is estimated to be AU$0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 5.1% in 2 years. Earnings is forecast to grow by 147% in the next 2 years. Major Estimate Revision • May 25
Consensus EPS estimates fall by 29%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from AU$213.7m to AU$215.9m. EPS estimate fell from AU$0.046 to AU$0.033 per share. Net income forecast to grow 50% next year vs 33% growth forecast for Personal Products industry in Australia. Consensus price target down from AU$0.72 to AU$0.62. Share price fell 2.6% to AU$0.56 over the past week. Price Target Changed • Mar 28
Price target decreased by 7.9% to AU$0.78 Down from AU$0.84, the current price target is an average from 2 analysts. New target price is 27% above last closing price of AU$0.61. Stock is down 33% over the past year. The company is forecast to post earnings per share of AU$0.021 for next year compared to AU$0.0026 last year. Buying Opportunity • Mar 20
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 13%. The fair value is estimated to be AU$0.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 6.9% in 2 years. Earnings is forecast to grow by 207% in the next 2 years. Reported Earnings • Mar 15
First half 2023 earnings: EPS misses analyst expectations First half 2023 results: EPS: AU$0.001 (up from AU$0.017 loss in 1H 2022). Revenue: AU$112.1m (up 2.9% from 1H 2022). Net income: AU$82.0k (up AU$2.23m from 1H 2022). Profit margin: 0.1% (up from net loss in 1H 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 96%. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 7.7% growth forecast for the Personal Products industry in Oceania. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Price Target Changed • Mar 15
Price target decreased by 11% to AU$0.84 Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 28% above last closing price of AU$0.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year. Buying Opportunity • Feb 27
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be AU$0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 3.3% per annum. Earnings is also forecast to grow by 41% per annum over the same time period. Announcement • Jan 23
McPherson's Limited Appoints Linda Gough as Company Secretary McPherson's Limited announced the appointment of Linda Gough to the role of Company Secretary, effective 16 January 2023. Ms. Gough has over twenty years legal and governance experience, advising listed and non-listed entities in ANZ, Asia and North America, including WPP AUNZ Limited, FairfaxMedia Limited, SAP Australia and George Weston Foods. She holds a Master of Laws from the University of New South Wales, as well as a graduate diploma in governance from the Governance Institute of Australia. Ms. Gough will be responsible for communication with the ASX under Rule 12.6. McPherson's existing Co-Company Secretary, Paul Witheridge, continues in his role. Price Target Changed • Jan 20
Price target decreased to AU$0.84 Down from AU$0.95, the current price target is an average from 3 analysts. New target price is 16% above last closing price of AU$0.72. Stock is down 12% over the past year. The company is forecast to post earnings per share of AU$0.056 for next year compared to AU$0.0026 last year. Announcement • Jan 17
McPherson's Limited to Report First Half, 2023 Results on Feb 28, 2023 McPherson's Limited announced that they will report first half, 2023 results on Feb 28, 2023 Major Estimate Revision • Dec 26
Consensus forecasts updated The consensus outlook for 2023 has been updated. 2023 EPS estimate fell from AU$0.07 to AU$0.06 per share. Revenue forecast steady at AU$228.2m. Net income forecast to grow 2,573% next year vs 20% growth forecast for Personal Products industry in Australia. Consensus price target broadly unchanged at AU$0.95. Share price rose 6.9% to AU$0.70 over the past week. Announcement • Oct 26
McPherson's Limited Announces Resignation of Geoffrey Pearce as Director, Effective November 22, 2022 McPherson's Limited announced that Geoffrey Pearce will resign as a Director with effect from the conclusion of the Company's Annual GeneralMeeting, which will be held on 22 November 2022. Mr. Pearce has served on the Board of McPherson's since February 2018. Announcement • Sep 30
McPherson's Limited, Annual General Meeting, Nov 22, 2022 McPherson's Limited, Annual General Meeting, Nov 22, 2022, at 11:01 AUS Eastern Standard Time. Location: at the offices of Thomson Geer, Level 14, 60 Martin Place, Sydney, 2000 Sydney Australia Upcoming Dividend • Aug 29
Upcoming dividend of AU$0.02 per share Eligible shareholders must have bought the stock before 05 September 2022. Payment date: 23 September 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 6.6%. Within top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (1.8%). Reported Earnings • Aug 26
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: AU$0.003 (up from AU$0.042 loss in FY 2021). Revenue: AU$214.2m (up 6.7% from FY 2021). Net income: AU$333.0k (up AU$5.37m from FY 2021). Profit margin: 0.2% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 83%. Over the next year, revenue is forecast to grow 6.1%, compared to a 12% growth forecast for the Personal Products industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Announcement • Aug 25
McPherson's Limited Declares Fully Franked Final Dividend for the Year 2022, Payable on 23 September 2022 Since the 2022 financial year end, the Directors of McPherson's Limited have declared a fully franked final dividend of 2.0 cents per fully paid share (2021: 1.5 cents per fully paid share). The aggregate amount of the dividend to be paid on 23 September 2022 but not recognised as a liability at year end. Record date for determining entitlements to the dividend 6 September 2022. Announcement • Aug 11
McPherson's Limited to Report Fiscal Year 2022 Results on Aug 25, 2022 McPherson's Limited announced that they will report fiscal year 2022 results on Aug 25, 2022 Reported Earnings • Feb 24
First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind First half 2022 results: AU$0.017 loss per share (down from AU$0.009 profit in 1H 2021). Revenue: AU$108.9m (up 6.8% from 1H 2021). Net loss: AU$2.14m (down 304% from profit in 1H 2021). Revenue missed analyst estimates by 100%. Earnings per share (EPS) exceeded analyst estimates by 649%. Over the next year, revenue is forecast to grow 7.3%, compared to a 20% growth forecast for the industry in Australia. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Announcement • Feb 22
McPherson's Limited Announces Changes to Its Board McPherson's Limited announced Mr. Graham Cubbin has retired from the board with effect from February 21, 2022. Mr. Cubbin has served on the board of McPherson's since September 2010, and held the role of chairman from July 1, 2015 until July 21, 2021. Following the appointment of Mr. Ari Mervis as chairman, Mr. Cubbin agreed to remain on the board, and as a member of the Audit, Risk management and compliance committee, which has ensured an orderly and effective transition. Announcement • Feb 16
McPherson's Limited to Report First Half, 2022 Results on Feb 23, 2022 McPherson's Limited announced that they will report first half, 2022 results on Feb 23, 2022 Price Target Changed • Sep 15
Price target decreased to AU$1.19 Down from AU$1.40, the current price target is an average from 2 analysts. New target price is 9.7% above last closing price of AU$1.09. Announcement • Jun 15
Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others. Arrotex Pharmaceuticals Pty Limited made a non-binding indicative offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex.
The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that indicative proposal will be subject to any material regulatory conditions.
Arrotex Pharmaceuticals Pty Limited cancelled the acquisition of McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others on June 15, 2021. Price Target Changed • May 17
Price target increased to AU$1.53 Up from AU$1.40, the current price target is an average from 3 analysts. New target price is 9.3% above last closing price of AU$1.40. Announcement • Apr 30
Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million. Arrotex Pharmaceuticals Pty Limited made a Non-binding Indicative Offer to acquire McPherson's Limited (ASX:MCP) from Investors Mutual Limited, Kin Group Pty Ltd, Microequities Asset Management Pty Limited, Lennox Capital Partners and others for approximately AUD 210 million on April 28, 2021. Offer will be made by scheme of arrangement. Under the transaction, Offeror will acquire 128.40346 million shares and 3.838 million Performance Right of McPherson's at a price of AUD 1.6 per share in cash. Pre transaction, Investors Mutual Limited holds 5.8 million shares representing 4.5% stake, Microequities Asset Management Pty Limited holds 7.5 million shares representing 5.8% stake, Lennox Capital Partners 8.3 million shares representing 6.9% stake and Kin Group Pty Ltd holds 6.4 million shares representing 4.95% stake in McPherson's. Arrotex Indicative Proposal can be fully funded via a combination of debt and existing Arrotex cash reserves. Arrotex has stated it would be open to the McPherson’s Board declaring a fully-franked special dividend payable to shareholders as part of the indicative offer price, subject to ATO approval, prior to completion of an agreed transaction with Arrotex.
The Arrotex Indicative Proposal is subject to a number of standard conditions, including completion of satisfactory due diligence within a 4 week period pertaining to accounting, financial, legal and key operational areas; entry into a scheme of implementation agreement on customary terms and conditions, including receipt of a unanimous recommendation from the McPherson’s Board for McPherson’s shareholders to vote in favour of the scheme; a break fee payable by McPherson’s to Arrotex compliant with the Takeovers Panel guidance; subject to the customary fiduciary outs in the event of McPherson’s receiving a superior offer, customary exclusivity arrangements; and final approval of the Arrotex Board and necessary approvals from Arrotex’s debt financier. Arrotex has further communicated that it does not anticipate that Indicative Proposal will be subject to any material regulatory conditions. Announcement • Apr 29
McPherson's Limited Provides Earnings Guidance for the Full Year 2021 McPherson's Limited provides earnings guidance for the full year 2021. The company providing quantitative guidance for fascial year 2021. Total full year sales revenue is forecast to decline from $222 million in fascial year 2020 to the range of $200 million to $205 million in fascial year 2021. Underlying Group fascial year 2021 earnings before interest and tax (EBIT) is forecast to be within a range of $10 million to $13 million; Underlying fascial year 2021 profit after tax is forecast to be in a range of $6 million to $8 million; and Underlying fascial year 2021 EPS is forecast to be in the range of 5.0cps to 6.5cps. Announcement • Feb 18
McPherson's Limited Not Providing Earnings Guidance Due to COVID-19 McPherson's Limited announced that There remains an elevated level of uncertainty pertaining to McPherson's short-term trading outlook, largely due to the difficulty of forecasting demand in China. Consumer behaviour will be difficult to gauge in the short term following an unexpected slowdown in the market in the last quarter of last year. It is therefore not possible to provide guidance at this stage, but it remains likely that underlying profit before tax and earnings per share for 2H21 and FY21 will be materially below 2H20 and FY20. Announcement • Feb 16
McPherson's Limited Appoints Ari Mervis as Independent, Non-Executive Director to the Board McPherson's Limited announced the appointment of Mr. Ari Mervis as an independent, non-executive Director to the Board, effective immediately. McPherson's has sought to appoint an additional non-executive Director with skills and experience to ensure that the Board composition continues to support the company's focused strategy to be a leader in Health, Wellness and Beauty, as well as complement the existing experience base of the Board. Ari has extensive global experience which spans a range of industries in branded goods, consumer staples, agriculture, food and beverages. Ari's recent executive roles have been Executive Chairman of Accolade Wines, MD and CEO of Murray Goulburn, and prior to that he spent 27 years at global brewer SABMiller where his career culminated as CEO of Carlton & United Breweries and MD Asia Pacific – a member of the global leadership team. Announcement • Feb 10
McPherson's Limited to Report First Half, 2021 Results on Feb 17, 2021 McPherson's Limited announced that they will report first half, 2021 results on Feb 17, 2021 Valuation Update With 7 Day Price Move • Dec 17
Investor sentiment improved over the past week After last week's 21% share price gain to AU$1.40, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.3x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 47%. Announcement • Dec 11
McPherson's CEO Change McPherson's Limited announced the following key changes to its executive team. Mr. Laurie McAllister has resigned from the Company as Chief Executive Officer and Managing Director, effective 9th December 2020. The Board thanks Mr. McAllister for his service over the past four years, noting that Laurie leaves the Company in a strong position for future growth, having successfully completed the recent Global Therapeutics acquisition, and notwithstanding the challenges arising from the COVID-19 pandemic. Mr. McAllister has agreed to remain available to the Company for a period following his resignation and to assist the Company and the McPherson's executive team as may be required. Mr. Grant Peck, who has been a non-executive Director on the McPherson's board since December 2017, will replace Mr. McAllister in the role of Chief Executive Officer and Managing Director on an interim basis, effective today. This will provide continuity and aid the transition to a new permanent CEO and Managing Director. Valuation Update With 7 Day Price Move • Dec 10
Market pulls back on stock over the past week After last week's 18% share price decline to AU$1.15, the stock is trading at a trailing P/E ratio of 20.3x, down from the previous P/E ratio of 24.7x. This compares to an average P/E of 25x in the Personal Products industry. Total returns to shareholders over the past three years are 31%. Is New 90 Day High Low • Dec 10
New 90-day low: AU$1.15 The company is down 61% from its price of AU$2.92 on 11 September 2020. The Australian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$1.58 per share. Price Target Changed • Dec 02
Price target lowered to AU$2.36 Down from AU$3.27, the current price target is an average from 4 analysts. The new target price is 89% above the current share price of AU$1.25. As of last close, the stock is down 48% over the past year. Major Estimate Revision • Dec 02
Analysts lower EPS estimates to AU$0.083 The 2021 consensus revenue estimate was lowered from AU$244.8m to AU$226.5m. Earning per share (EPS) estimate was also lowered from AU$0.14 to AU$0.083 for the same period. Net income is expected to grow by 95% next year compared to 25% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.27 to AU$2.36. Share price is down by 40% to AU$1.25 over the past week. Valuation Update With 7 Day Price Move • Nov 30
Market pulls back on stock over the past week After last week's 16% share price decline to AU$1.83, the stock is trading at a trailing P/E ratio of 32.2x, down from the previous P/E ratio of 38.2x. This compares to an average P/E of 26x in the Personal Products industry. Total returns to shareholders over the past three years are 102%. Is New 90 Day High Low • Nov 18
New 90-day low: AU$2.18 The company is down 26% from its price of AU$2.95 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.67 per share. Major Estimate Revision • Oct 30
Analysts update estimates The 2021 consensus revenue estimate increased from AU$233.4m to AU$238.9m. Earnings per share (EPS) estimate was lowered from AU$0.16 to AU$0.14 for the same period. Net income is expected to grow by 164% next year compared to 20% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 10% to AU$2.27 over the past week. Announcement • Oct 29
McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million. McPherson's Limited has completed a Follow-on Equity Offering in the amount of AUD 36.547 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 16,100,000
Price\Range: AUD 2.27
Discount Per Security: AUD 0.0454
Transaction Features: Subsequent Direct Listing Major Estimate Revision • Oct 28
Analysts update estimates The 2021 consensus earning per share (EPS) estimate was lowered from AU$0.17 to AU$0.15. Revenue estimate was approximately flat at AU$236.9m. Net income is expected to grow by 174% next year compared to 21% growth forecast for the Personal Products industry in Australia. The consensus price target was lowered from AU$3.55 to AU$3.51. Share price is down by 14% to AU$2.28 over the past week. Is New 90 Day High Low • Oct 21
New 90-day low: AU$2.64 The company is down 12% from its price of AU$3.00 on 23 July 2020. The Australian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$3.85 per share. Announcement • Aug 07
McPherson's Limited to Report Fiscal Year 2020 Results on Aug 19, 2020 McPherson's Limited announced that they will report fiscal year 2020 results at 6:19 AM, GMT Standard Time on Aug 19, 2020